首页> 外文期刊>Molecular medicine reports >MicroRNA-26a-modified adipose-derived stem cells incorporated with a porous hydroxyapatite scaffold improve the repair of bone defects
【24h】

MicroRNA-26a-modified adipose-derived stem cells incorporated with a porous hydroxyapatite scaffold improve the repair of bone defects

机译:MicroRNA-26A改性的脂肪衍生的干细胞掺入多孔羟基磷灰石支架,改善了骨缺损的修复

获取原文
获取原文并翻译 | 示例
           

摘要

Tissue-engineered bone substitutes are frequently used to repair bone defects. Adipose-derived stem cells (ASCs) are a promising source of cells for repairing bone tissue, however, insufficient osteogenic potency remains the main obstacle for their application. The present study aimed to enhance the osteogenic potency of ASCs by transfection of microRNA (miR)-26a, a novel osteogenic and angiogenic promoting miRNA. An inverted fluorescence microscope was used to observe transfection efficiency, while a scanning electron microscope was used to detect morphological alterations. Cell proliferation was monitored continuously for 7 days using a Cell Counting kit-8 assay. Osteogenic differentiation was determined by reverse transcription quantitative polymerase chain reaction, alkaline phosphatase (ALP) staining, collagen secretion and extracellular matrix (ECM) mineralization. ASCs were incorporated with a porous hydroxyapatite (HA) scaffold to create a novel tissue-engineered bone substitute and inserted into the critical tibia defect of rats. New bone formation was evaluated by hematoxylin and eosin and Masson's trichrome staining. The results demonstrated that miR-26a was successfully delivered into the cytoplasm, while the morphology and proliferation of ASCs were not significantly altered. Osteogenic-associated genes were markedly upregulated and ALP production, collagen secretion and ECM mineralization were all increased following transfection of miR-26a. Histological evaluation demonstrated that the modified cells accompanied with a porous HA scaffold markedly promoted new bone formation within the defective area. In conclusion, miR-26a transfection significantly improved the osteogenic potency of ASCs suggesting that modified ASCs incorporated with a HA scaffold may be used as a potential bone substitute.
机译:组织工程骨代替物经常用于修复骨缺陷。脂肪衍生的干细胞(ASCS)是用于修复骨组织的有前途的细胞来源,然而,骨质发生不足效力仍然是其应用的主要障碍。本研究旨在通过对微小RONS(miR)-26a,一种新的骨质发生和血管生成的miRNA来增强ASCS的骨质发生效力。使用倒荧光显微镜观察转染效率,而扫描电子显微镜用于检测形态改变。使用细胞计数试剂盒-8测定,连续监测细胞增殖7天。通过逆转录定量聚合酶链反应,碱性磷酸酶(ALP)染色,胶原分泌和细胞外基质(ECM)矿化来确定骨质发生分化。 ASC掺入多孔羟基磷灰石(HA)支架中,以产生新型组织工程骨替代品,并插入大鼠的关键胫骨缺陷。通过苏木精和曙红和马隆的三色染色来评估新的骨形成。结果表明,MiR-26A成功递送到细胞质中,而ASCS的形态和增殖不会显着改变。骨质发生相关基因明显上调,胶原蛋白分泌和ECM矿化在MiR-26a的转染后全部增加。组织学评价证明,改性细胞伴有多孔HA支架,明显促进了缺陷区域内的新骨形成。总之,MiR-26A转染显着改善了ASC的骨质发生效力,提示掺入HA支架的修饰ASC可以用作潜在的骨代替。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号